Literature DB >> 12626356

Role of oxidative stress in angiotensin-induced hypertension.

Jane F Reckelhoff1, J Carlos Romero.   

Abstract

Infusion of ANG II at a rate not sufficient to evoke an immediate vasoconstrictor response, produces a slow increase in blood pressure. Circulating levels of ANG II may be within ranges found in normotensive individuals, although inappropriately high with respect to sodium intake. When ANG II levels are dissociated from sodium levels, oxidative stress (OXST) occurs, which can increase blood pressure by several mechanisms. These include inadequate production or reduction of bioavailability of nitric oxide, alterations in metabolism of arachidonic acid, resulting in an increase in vasoconstrictors and decrease in vasodilators, and upregulation of endothelin. This cascade of events appears to be linked, because ANG II hypertension can be blocked by inhibition of any factor located distally, blockade of ANG II, OXST, or endothelin. Such characteristics are shared by other models of hypertension, such as essential hypertension, hypertension induced by reduction in renal mass, and renovascular hypertension. Thus these findings are clinically important because they reveal 1) uncoupling between ANG II and sodium, which can trigger pathological conditions; 2) the various OXST mechanisms that may be involved in hypertension; and 3) therapeutic interventions for hypertension developed with the knowledge of the cascade involving OXST.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12626356     DOI: 10.1152/ajpregu.00491.2002

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  67 in total

Review 1.  Inflammation and atherosclerosis.

Authors:  Mehdi H Shishehbor; Deepak L Bhatt
Journal:  Curr Atheroscler Rep       Date:  2004-03       Impact factor: 5.113

2.  Gene expression profiles linked to AT1 angiotensin receptors in the kidney.

Authors:  Natalia A Makhanova; Steven D Crowley; Robert C Griffiths; Thomas M Coffman
Journal:  Physiol Genomics       Date:  2010-08-31       Impact factor: 3.107

3.  Synergistic actions of enalapril and tempol during chronic angiotensin II-induced hypertension.

Authors:  Ahmed A Elmarakby; Jan M Williams; John D Imig; Jennifer S Pollock; David M Pollock
Journal:  Vascul Pharmacol       Date:  2006-09-26       Impact factor: 5.773

4.  The cerebrovascular dysfunction induced by slow pressor doses of angiotensin II precedes the development of hypertension.

Authors:  Carmen Capone; Giuseppe Faraco; Laibaik Park; Xian Cao; Robin L Davisson; Costantino Iadecola
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-10-22       Impact factor: 4.733

5.  Asymmetric dimethylarginine in angiotensin II-induced hypertension.

Authors:  Jennifer M Sasser; Natasha C Moningka; Mark W Cunningham; Byron Croker; Chris Baylis
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-12-16       Impact factor: 3.619

6.  Attenuation of angiotensin II-induced hypertension and cardiac hypertrophy in transgenic mice overexpressing a type 1 receptor mutant.

Authors:  Saad Ahmad; Francesca Cesana; Edward Lamperti; Haralambos Gavras; Jun Yu
Journal:  Am J Hypertens       Date:  2009-09-24       Impact factor: 2.689

7.  Interleukin-10 negatively modulates extracellular signal-regulated kinases 1 and 2 in aorta from hypertensive mouse induced by angiotensin II infusion.

Authors:  Alecsander F Bressan; Gisele A Fonseca; Rita C Tostes; R Clinton Webb; Victor Vitorino Lima; Fernanda Regina Giachini
Journal:  Fundam Clin Pharmacol       Date:  2018-09-07       Impact factor: 2.748

8.  Angiotensin II infusion induces nephrin expression changes and podocyte apoptosis.

Authors:  Junya Jia; Guohua Ding; Jili Zhu; Cheng Chen; Wei Liang; Nicholas Franki; Pravin C Singhal
Journal:  Am J Nephrol       Date:  2008-01-17       Impact factor: 3.754

9.  Exogenous L-arginine ameliorates angiotensin II-induced hypertension and renal damage in rats.

Authors:  Niwanthi W Rajapakse; Carmen De Miguel; Satarupa Das; David L Mattson
Journal:  Hypertension       Date:  2008-11-03       Impact factor: 10.190

10.  Nitric oxide, prostaglandins and angiotensin II in the regulation of renal medullary blood flow during volume expansion.

Authors:  Carol Moreno; María T Llinás; Francisca Rodriguez; Juan M Moreno; F Javier Salazar
Journal:  J Physiol Biochem       Date:  2015-11-26       Impact factor: 4.158

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.